IO Biotech, Inc. (IOBTQ)
OTCMKTS · Delayed Price · Currency is USD
0.0020
+0.0019 (1,900.00%)
At close: Aug 10, 2026
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $7.2 thousand as of August 10, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
7.20K
Enterprise Value
-12.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since November 8, 2021, IO Biotech's market cap has decreased from 364.82M to 7.20K, a decrease of -100.00%. That is a compound annual growth rate of -89.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 143.90K | -99.67% |
| Dec 31, 2025 | 43.81M | -27.72% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -49.45% |
| Nov 8, 2021 | 364.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Windtree Therapeutics | 9.00K |
| Bioasis Technologies | 7.94K |
| Therapeutic Solutions International | 7.05K |
| Entia Biosciences | 6.81K |
| U.S. Stem Cell | 6.62K |
| NovAccess Global | 6.17K |
| Theralink Technologies | 6.15K |
| MetaStat | 5.88K |